• The rising prevalence of cardiovascular diseases and an aging global population are significantly increasing the incidence of aortic aneurysms, driving consistent market demand.

• Growing preference for minimally invasive procedures like Endovascular Aneurysm Repair (EVAR) and Thoracic Endovascular Aortic Repair (TEVAR) is reshaping the treatment landscape.

• Advancements in stent graft technology, including branched and fenestrated devices, are enhancing treatment precision and patient recovery outcomes.

• Integration of AI-driven diagnostics and 3D imaging is improving early detection, treatment planning, and post-operative monitoring for better patient management.

• North America leads due to advanced healthcare infrastructure and high awareness levels, while Asia-Pacific shows strong growth potential fueled by healthcare modernization.

• Increasing collaborations among medical device manufacturers, hospitals, and research institutions are accelerating product innovation and regulatory approvals.

• Focus on preventive screening programs and value-based care initiatives is expanding the market scope and improving long-term patient outcomes.

In this report, the Aortic Aneurysm Market has been segmented by Type, Product, Treatment, End User, and Geography.

Aortic Aneurysm Market, Segmentation by Type

The Type segmentation includes Abdominal Aortic Aneurysm (AAA) and Thoracic Aortic Aneurysm (TAA). Both conditions vary in prevalence and treatment approach, yet contribute significantly to overall disease burden worldwide.

Abdominal Aortic Aneurysm (AAA)

Abdominal Aortic Aneurysm (AAA) represents the most common form, accounting for the majority of diagnosed cases. It is typically associated with atherosclerosis, smoking, hypertension, and advanced age. The rising availability of screening programs and endovascular repair options has improved early detection and survival rates. Increased adoption of EVAR procedures and the use of customized stent grafts are driving growth in this segment.

Thoracic Aortic Aneurysm (TAA)

Thoracic Aortic Aneurysm (TAA) occurs less frequently but poses higher surgical complexity and mortality risks. It is often linked to connective tissue disorders and genetic conditions such as Marfan and Ehlers-Danlos syndromes. The growing use of advanced imaging and hybrid endovascular approaches is improving clinical outcomes in TAA management. Technological progress in branched and fenestrated stent grafts continues to enhance procedural precision.

Aortic Aneurysm Market, Segmentation by Product

The Product segmentation includes Stent Grafts, Catheters, and Others. Innovations in device materials, design, and deployment systems have transformed the treatment landscape, emphasizing minimally invasive and patient-specific therapies.

Stent Grafts

Stent Grafts hold the dominant market share, serving as the cornerstone for endovascular aneurysm repair (EVAR and TEVAR). These devices reinforce weakened aortic walls, preventing rupture and improving blood flow. Continuous R&D in biocompatible materials and modular stent designs enhances their flexibility and long-term stability, contributing to higher adoption rates.

Catheters

Catheters are essential tools for the delivery and positioning of stent grafts during endovascular procedures. The demand for precision-guided catheters is increasing with the advancement of imaging-assisted interventions. Catheter innovation—such as hydrophilic coatings and steerable designs—is expanding their role in complex aneurysm repairs.

Others

The Others segment includes guidewires, balloons, and closure devices used in endovascular procedures. Their growing integration into minimally invasive vascular repair systems enhances procedural efficiency and patient outcomes, especially in hospitals with hybrid operating environments.

Aortic Aneurysm Market, Segmentation by Treatment

The Treatment segmentation includes Endovascular Aneurysm Repair (EVAR) and Open Surgical Repair (OSR). The evolution from traditional open surgery to less invasive endovascular techniques has dramatically reshaped treatment preferences worldwide.

Endovascular Aneurysm Repair (EVAR)

Endovascular Aneurysm Repair (EVAR) dominates the treatment landscape due to its lower procedural risk, shorter hospital stay, and faster recovery. EVAR involves inserting a stent graft through small incisions, guided by real-time imaging. The ongoing introduction of next-generation devices and robotic-assisted systems is making this approach more precise and widely adopted in both developed and emerging markets.

Open Surgical Repair (OSR)

Open Surgical Repair (OSR) remains critical for patients with complex aneurysm anatomy or contraindications to EVAR. Although more invasive, OSR provides durable long-term results, particularly for younger or lower-risk patients. Continuous improvement in surgical techniques, anesthesia, and postoperative care sustains its relevance in advanced healthcare settings.

Aortic Aneurysm Market, Segmentation by End User

The End User segmentation includes Hospitals & Clinics, Ambulatory Surgery Centers (ASCs), and Others. Each category reflects varying levels of procedural specialization and infrastructure availability.

Hospitals & Clinics

Hospitals & Clinics dominate the market as they are equipped with advanced imaging systems, hybrid operating rooms, and multidisciplinary vascular teams. The rising number of EVAR procedures performed in tertiary care hospitals highlights this segment’s leadership in global aneurysm treatment.

Ambulatory Surgery Centers (ASCs)

Ambulatory Surgery Centers (ASCs) are gaining popularity for performing minimally invasive endovascular repairs. Their cost-effectiveness, faster patient turnaround, and lower infection risk make them attractive alternatives to traditional hospital settings. Increasing adoption of day-care EVAR procedures is boosting this segment’s growth.

Others

The Others category includes research institutions and specialty cardiac centers focused on clinical trials, device testing, and post-surgical rehabilitation. Collaborations between device manufacturers and healthcare providers are enhancing innovation and access to new treatment options.

Aortic Aneurysm Market, Segmentation by Geography

In this report, the Aortic Aneurysm Market has been segmented by Geography into five regions: North America, Europe, Asia Pacific, Middle East & Africa and Latin America.

North America

North America leads the global aortic aneurysm market, supported by high disease prevalence, advanced healthcare infrastructure, and strong reimbursement policies. The U.S. remains a key contributor with widespread adoption of endovascular repair technologies and hybrid vascular centers.

Europe

Europe demonstrates significant growth, driven by rising geriatric populations and expanding adoption of EVAR and TEVAR procedures. Countries such as Germany, France, and the U.K. are focusing on technological upgrades and minimally invasive treatment research to improve patient outcomes.

Asia Pacific

Asia Pacific is the fastest-growing region, fueled by increasing cardiovascular disease prevalence, improving diagnostic facilities, and growing healthcare investments. Rapid urbanization and awareness programs in China, Japan, and India are expanding access to advanced endovascular treatment options.

Middle East & Africa

Middle East & Africa are emerging markets, where the demand for modern vascular care infrastructure and skilled professionals is rising. Government initiatives to strengthen cardiovascular treatment capabilities are expected to accelerate market penetration in the coming years.

Latin America

Latin America shows moderate but steady growth, led by Brazil and Mexico. Increasing healthcare expenditure, along with the introduction of advanced stent graft technologies, is enhancing the regional treatment landscape for aortic aneurysm repair.